{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:09:14Z","timestamp":1783912154263,"version":"3.55.0"},"reference-count":139,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Drug Targeting"],"published-print":{"date-parts":[[2021,1,2]]},"DOI":"10.1080\/1061186x.2020.1803886","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T12:33:24Z","timestamp":1596112404000},"page":"46-59","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Injectable\n            <i>in-situ<\/i>\n            gel depot system for targeted delivery of biologics to the retina"],"prefix":"10.1080","volume":"29","author":[{"given":"Rohit","family":"Bisht","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Translational Pharmaceutics Research Laboratory, Birla Institute of Technology and Science (BITS)-Pilani","place":["Hyderabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Nirmal","sequence":"additional","affiliation":[{"name":"School of Material Science and Engineering, Nanyang Technological University","place":["Singapore, Singapore"]},{"name":"Incozen Therapeutics Pvt. Ltd","place":["Hyderabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Agrawal","sequence":"additional","affiliation":[{"name":"School of Material Science and Engineering, Nanyang Technological University","place":["Singapore, Singapore"]},{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav K.","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayabalan","family":"Nirmal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Translational Pharmaceutics Research Laboratory, Birla Institute of Technology and Science (BITS)-Pilani","place":["Hyderabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2016.1284"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2009.01.002"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.01.008"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118767"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.05.001"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3790"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.06.043"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.12"},{"key":"e_1_3_3_10_1","unstructured":"Data MIntillegance. Monoclonal antibodies therapeutics market size outlook and growth opportunities 2019\u20132026 [Internet]; 2020 [cited 2020 Apr 16]. Available from: https:\/\/www.datamintelligence.com\/research-report\/monoclonal-antibody-therapeutics-market."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.08.001"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1227783"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10260"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2495-0"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S40215"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/DIJN.1.S624"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S94188"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2017.08.008"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2020.01.015"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.037"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S97653"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.07.026"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2019.1618829"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.05.031"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.10.015"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.17"},{"key":"e_1_3_3_27_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Safety and efficacy of AbiciparPegol in patients with neovascular age-related macular degeneration; 2019 [cited 2019 Jul 24]. ID:NCT02462486. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02462486."},{"key":"e_1_3_3_28_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Safety and efficacy of AbiciparPegol in patients with neovascular age-related macular degeneration (CDER); 2019 [cited 2019 Jun 19]. ID: NCT02462928. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02462.928?term=02462928&draw=2&rank=1."},{"key":"e_1_3_3_29_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Phae-2 randomized clinical trial of Luminate\u00ae as compared to Avastin\u00ae in the treatment of diabetic macular edema; 2018 [cited 2018 Dec 7]. ID: NCT02348918. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02348918?term=02348918&draw=2&rank=1."},{"key":"e_1_3_3_30_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Efficacy and safety trial of Conbercept intravitreal injection for neovascular age-related macular degeneration (PANDA-2); 2019 [cited 2019 Mar 5] ID: NCT03630952. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03630952?term=03630952&draw=2&rank=1."},{"key":"e_1_3_3_31_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Clinical study to investigate safety and efficacy of GSK933776 in adult patients with geographic atrophy secondary to age-related macular degeneration; 2017 [cited 2017 May 5]. ID: NCT01342926. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01342926?term=01342926&draw=2&rank=1."},{"key":"e_1_3_3_32_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Efficacy and safety study of iSONEP with and without Lucentis\/Avastin\/Eylea to treat wetAMD (Nexus); 2016 [cited 2016 Oct 17]. ID: NCT01414153. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01414153.?term=01414153&draw=2&rank=1."},{"key":"e_1_3_3_33_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Safety and tolerability of RN6G in patients with dry age-related macular degeneration; 2015 [cited 2015 Mar 31]. ID: NCT00877032. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00877032?term=00877032&draw=2&rank=1."},{"key":"e_1_3_3_34_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Efficacy and safety of RTH258 versus Aflibercept-Study1 (HAWK); 2019 [cited 2019 Oct 31]. ID: NCT02307682. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02307682?term=02307682&draw=2&rank=1."},{"key":"e_1_3_3_35_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Efficacy and safety of ESBA1008 versus EYLEA\u00ae; 2016 [cited 2016 Feb 9]. ID: NCT01796964. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01796964?term=01796964&draw=2&rank=1."},{"key":"e_1_3_3_36_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. A dose ranging study of OP-302 with Ranibizumab in Neovascular (Wet) AMD; 2020 [cited 2020 Jan 21]. ID: NCT03345082. Available from:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03345082.?term=03345082&draw=2&rank=1."},{"key":"e_1_3_3_37_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Study evaluating intravitreal h1-con1\u2122 in patients with choroidal neovascularization secondary to age-related macular degeneration (EMERGE); 2017 [cited 2017 Dec 2]. ID: NCT02358889. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02358889?term=02358889&draw=2&rank=1."},{"key":"e_1_3_3_38_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. A study to establish the safety and tolerability of ZImura (Anti-c5 Aptamer) in Combination with anti-VEGF therapy in subjects with idiopathic polypoidal choroidal vasculopathy (IPCV); 2019 [cited 2019 Jan 23]. ID: NCT02397954. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02397954?term=02397954&draw=2&rank=1."},{"key":"e_1_3_3_39_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. ZIMURA in combination with LUCENTIS in patients with neovaculat age-related macular degeneration (NVAMD); 2019 [cited 2019 Nov 6].ID:NCT03362190. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03362190?term=03362190&draw=2&rank=1."},{"key":"e_1_3_3_40_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Study to evaluate faricimab (RO6867461; RG7716) for extended durability in the treatment of neovascular age related macular degeneration (nAMD); 2020 [cited 2020 Jan 7]. ID: NCT03038880. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03038880?term=03038880&draw=2&rank=1."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.03.023"},{"key":"e_1_3_3_42_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. A study to evaluate the safety and efficacy of THR-317 for the treatment of diabetic macular oedema; 2018 [cited 2018 Apr 18]. ID: NCT03071068. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03071068?term=03071068&draw=2&rank=1."},{"key":"e_1_3_3_43_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. TAB014(Drug code) in wet5 (Neovascular) age-related macular degeneration (AMD) subjects; 2018 [cited 2018 Sep 26]. ID: NCT03675880. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03675880?term=03675880&draw=2&rank=1."},{"key":"e_1_3_3_44_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. A study of multiple intravitreal injection of TK001 in patuients with neovascular age-related macular degeneration; 2018 [cited 2018 Mar 1]. ID: NCT03021785. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03021785?term=03021785&draw=2&rank=1."},{"key":"e_1_3_3_45_1","unstructured":"USFDA. [Internet]. FDA approves first treatment for thyroid eye disease; 2020 [updated 2020 Jan 21; cited 2020 Apr 20]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-thyroid-eye-disease."},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1105"},{"key":"e_1_3_3_47_1","unstructured":"ISRCTN registery. [Internet]Randomised placebo controlled patient and observer masked study to evaluate the efficacy of treatment with Sandostatin\u00ae LAR 20\u2009mg intramuscularly (i.m.) or placebo every 4 weeks during 6 months in 120 patients with exudative age-related macular degeneration; 2018 [cited Nov 2018]. ID:16381123. Available from: https:\/\/www.isrctn.com\/ISRCTN16381123?q=16381123&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basicsearch."},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.109380"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000219683"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.9.1353"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2012.08.005"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac4882"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.09.004"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701792"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0443"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2012.106"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12330"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.03.043"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X15666191218094020"},{"key":"e_1_3_3_60_1","unstructured":"ClinicalTrials.gov. [Internet] US National Library of Medicine. Intravitreal bone marrow-derived stem cells in patients with macular degeneration (AMDCELL); 2017 [cited 2017Jul 21]. ID: NCT01518127.Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01518127?term=01518127&draw=2&rank=1."},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20740"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470595886.ch2"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-0045-6"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2005.09.005"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi061500t"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20823"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvp003"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00152-0"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018981208076"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3011.1996.tb00821.x"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2007.09.027"},{"issue":"2","key":"e_1_3_3_72_1","first-page":"245","article-title":"Glycation of monoclonal antibodies impairs their ability to bind antigen","volume":"98","author":"Kennedy DM","year":"2008","unstructured":"Kennedy DM, Skillbn AW, Self CH. Glycation of monoclonal antibodies impairs their ability to bind antigen. ClinExpImmunol. 2008;98(2):245\u2013251.","journal-title":"ClinExpImmunol"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M709987200"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018893115557"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0004(90)90124-T"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1063\/1.2991176"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920109788488932"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2015.11.002"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.04.040"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21526"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1021\/js970034d"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfoodeng.2005.10.028"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.22525"},{"key":"e_1_3_3_84_1","first-page":"253","article-title":"Solvent stabilization of protein structure","volume":"40","author":"Timasheff SN.","year":"1995","unstructured":"Timasheff SN. Solvent stabilization of protein structure. Methods Mol Biol. 1995;40:253\u2013269.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2009.06.004"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000008042.15988.c0"},{"issue":"1","key":"e_1_3_3_87_1","first-page":"11","article-title":"The citrate ion increases the conformational stability of \u03b11-antitrypsin","volume":"1481","author":"Bottomley SP","year":"2000","unstructured":"Bottomley SP, Tew DJ. The citrate ion increases the conformational stability of \u03b11-antitrypsin. BiochimBiophysActa. 2000;1481(1):11\u201317.","journal-title":"BiochimBiophysActa"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2009.04.004"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1021\/bm8002557"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.45.525"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1021\/js970135b"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.01.016"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21504"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1051"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600760802"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.03.011"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.05.016"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.15171\/bi.2015.31"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.polymer.2008.01.027"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/polb.23081"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1039\/C1CS15203C"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.02.001"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.04.001"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2009.0059"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2004.12.007"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9408-z"},{"key":"e_1_3_3_107_1","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"4","author":"Ambati J","year":"2000","unstructured":"Ambati J, Canakis CS, Miller JW, et\u00a0al. Diffusion of high molecular weight compounds through sclera. InvestigOphthalmol Vis Sci. 2000;4:1181\u20131185.","journal-title":"InvestigOphthalmol Vis Sci"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi9802317"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23387"},{"key":"e_1_3_3_110_1","doi-asserted-by":"crossref","unstructured":"Cheruvu NPS Kompella UB. Bovine and porcine transscleral solutetransport: influence of lipophilicity and the Choroid-Bruch's layer. Invest Ophtalmol Vis Sci. 2006;47(10):4513\u20134522.","DOI":"10.1167\/iovs.06-0404"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde.11.104"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.4.2.5"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.progpolymsci.2014.07.006"},{"issue":"11","key":"e_1_3_3_114_1","first-page":"1088","article-title":"Responsive polymers incontrolled drug delivery","volume":"33","author":"Bajpai AK","year":"2008","unstructured":"Bajpai AK, Shukla SK, Bhanu S, et\u00a0al. Responsive polymers incontrolled drug delivery. ProgPolym Sci. 2008;33(11):1088\u20131118.","journal-title":"ProgPolym Sci"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00203-4"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2019.08.001"},{"issue":"13","key":"e_1_3_3_117_1","first-page":"3873","article-title":"Thermo-responsive hydrogel drug delivery system for the posterior segment of the eye","volume":"49","author":"Mieler WF","year":"2008","unstructured":"Mieler WF, Drapala P, Benac S, et\u00a0al. Thermo-responsive hydrogel drug delivery system for the posterior segment of the eye. Invest Ophthalmol Vis Sci. 2008;49(13):3873.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.04.053"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1021\/bm2009558"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9BM01049A"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.05.071"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1163334"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp300716t"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1021\/bm101233m"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2017.06.006"},{"key":"e_1_3_3_126_1","first-page":"1","article-title":"Photo-modulated therapeutic protein release from a hydrogel depot using visible light","volume":"128","author":"Basuki JS","year":"2016","unstructured":"Basuki JS, Qie F, Mulet X, et\u00a0al. Photo-modulated therapeutic protein release from a hydrogel depot using visible light. Angew Chem. 2016;128:1\u20136.","journal-title":"Angew Chem"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2013.05.034"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.12.029"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2013.09.029"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.01.058"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.1.12"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.3109\/02652048.2015.1134685"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.11.028"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.11.012"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13120"},{"key":"e_1_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.3233\/THC-199015"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2017.1302590"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1166\/jctn.2015.3799"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2015.1101140"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.08.025"}],"container-title":["Journal of Drug Targeting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1061186X.2020.1803886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:16:31Z","timestamp":1750666591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1061186X.2020.1803886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,2]]}},"alternative-id":["10.1080\/1061186X.2020.1803886"],"URL":"https:\/\/doi.org\/10.1080\/1061186x.2020.1803886","relation":{},"ISSN":["1061-186X","1029-2330"],"issn-type":[{"value":"1061-186X","type":"print"},{"value":"1029-2330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}